|
KR20200044705A
|
|
Method and Apparatus for Screening of Drugs Targeting Heterodimer of HER2 and HER3 and Method for Screening the Same
|
|
KR20200044706A
|
|
Method for Predicting Recurrence of Breast Cancer
|
|
WO2020080672A1
|
|
Method for analyzing pd-l1/pd-1 interaction, pd-l1/pd-1 interaction inhibitor, and method for screening said inhibitor
|
|
KR20210001095A
|
|
Pharmaceutical Composition for Inhibiting Interaction of PD-L1 and PD-1 and Method of Screening an Inhibitor
|
|
WO2019132517A1
|
|
Method and apparatus for analyzing intracellular or intercellular protein-protein interaction
|
|
WO2018194406A1
|
|
Method and apparatus for analysis of protein-protein interaction
|
|
KR20180117529A
|
|
Method for predicting drug responsiveness by protein-protein interaction analysis
|
